![Howard Grossberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Howard Grossberg
Nessuna posizione attualmente
Profilo
Howard Grossberg was Chief Medical Officer of Forest Laboratories, Inc.
Precedenti posizioni note di Howard Grossberg
Società | Posizione | Fine |
---|---|---|
BioTransplant, Inc.
![]() BioTransplant, Inc. Pharmaceuticals: MajorHealth Technology BioTransplant, Inc. is a life science company. The company discovers, develops and commercializes therapeutics, therapeutic devices and therapeutic regimens designed to suppress undesired immune responses and enhance the body's ability to accept donor cells, tissues and organs. The company was founded on March 20, 1990 and is headquartered in Charlestown, MA. | Corporate Officer/Principal | - |
FOREST LABORATORIES, INC. | Direttore Tecnico/Scientifico/R&S | - |
W WORL | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
W WORL | Health Technology |
Aziende private | 2 |
---|---|
BioTransplant, Inc.
![]() BioTransplant, Inc. Pharmaceuticals: MajorHealth Technology BioTransplant, Inc. is a life science company. The company discovers, develops and commercializes therapeutics, therapeutic devices and therapeutic regimens designed to suppress undesired immune responses and enhance the body's ability to accept donor cells, tissues and organs. The company was founded on March 20, 1990 and is headquartered in Charlestown, MA. | Health Technology |
Forest Laboratories, Inc.
![]() Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Howard Grossberg